ChemoCentryx’s Avacopan Scores European Approval For ANCA
The European Union has approved ChemoCentryx Inc's (NASDAQ: CCXI) Tavneos (avacopan) for…
Key Proteo Submits De Novo Application to FDA for its First Newborn Screening Kit – Chinook Observer
Key Proteo Submits De Novo Application to FDA for its First Newborn…
Seattle Children’s Research Institute & Genezen Partner To Advance XLA Gene Therapy
Seattle Children’s Research Institute, the research division of Seattle Children’s Hospital, and…
Genezen Announces Strategic Process Development and Manufacturing Partnership Agreement with Seattle Children’s Research Institute for X-linked Agammaglobulinemia (XLA) Cell Therapy Program
Seattle Children's Research Institute will be one of Genezen's first customers to…
Project 1: Program in Cell Signaling
Selected references Transcriptional signatures of Itk-deficient CD3+, CD4+ and CD8+ T-cells.Blomberg KE,…
Laura Greene’s son’s “gift of life” kidney transplant
An Irish woman living in the US who was diagnosed with an…
Two children suffering from rare diseases treated at Delhi hospital
New Delhi, A four-year-old girl suffering from a rare congenital condition, whose…
Immunodeficiency disorders – UF Health
DefinitionImmunodeficiency disorders occur when the body's immune response is reduced or absent.…
Hansa starts dosing in Phase III trial in anti-GBM disease
Sweden-based Hansa Biopharma doses first anti-GMB patient with imlifidase in a Phase…